Javier Amione‐Guerra

Statistics

Publications

Citations

319

H-Index

Active since

2016

Affiliations

The University of Texas Health Science Center at Houston(Current)

Houston Methodist

Baylor College of Medicine

Methodist Hospital

Javier Amione‐Guerra is an author at The University of Texas Health Science Center at Houston specializing in life sciences, pulmonary hypertension, and interstitial lung disease.

ORCID

Publications per year

2016–2017

Publications

Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension

Ning-Yuan Chen, Scott D. Collum, Fayong Luo et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2016 · 81 citations

Life Sciences, Immunology, Pathobiology +17

HIF1A up‐regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis

Kemly Philip, Weng Tingting Mills, Jonathan Davies et al. · The FASEB Journal · 2017 · 79 citations

Life Sciences, Molecular Biology, Pharmacology +17

Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis

Scott D. Collum, Ning‐Yuan Chen, Adriana M. Hernandez et al. · British Journal of Pharmacology · 2017 · 64 citations · Full text

Medicine, Biochemistry, Pharmacology +15

A Specifically Designed Nanoconstruct Associates, Internalizes, Traffics in Cardiovascular Cells, and Accumulates in Failing Myocardium: A New Strategy for Heart Failure Diagnostics and Therapeutics

Guillermo U. Ruiz‐Esparza, Víctor Segura-Ibarra, Andrea M. Cordero‐Reyes et al. · European Journal of Heart Failure · 2016 · 43 citations · Full text

Life Sciences, Bioengineering, Cardiology +13

Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension

Víctor Segura-Ibarra, Javier Amione‐Guerra, A.S. Cruz-Solbes et al. · International Journal of Pharmaceutics · 2017 · 35 citations

Pharmacy, Pharmaceutics, Pharmacotherapy +16

1–5 of 6